For Immediate Release

ChromaDex to Host Investor Conference Call on Recent Developments

IRVINE, Calif., July 12, 2010—ChromaDex Corporation (OTCBB: CDXC) announced today that it will host a conference call with its shareholders on Thursday, July 15, 2010 at 1:15 p.m. PT. The Company’s President and CEO, Frank Jaksch, will discuss recent developments at the company. Dr. Phillip Frost of the Frost Group, LLC will also be giving a short introduction.

Date:                     Thursday, July 15, 2010
Time:                    1:15 p.m. PT (4:15 p.m. ET)
Participate:        To access the webcast, register at https://www1.gotomeeting.com/register/129102369. Once registered, participants will be provided with a webcast link and dial-in number. Questions can be submitted through the webcast.  The webcast will be archived on the company website following the call.

About ChromaDex

ChromaDex is a leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property. ChromaDex is committed to sustainable "green chemistry" and provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the novel ingredients, analytical tools and services to meet product regulatory, quality, efficacy and safety standards. Among other things, the Company is currently focusing on clinical studies and the commercialization of its new product, pTeroPure™ pterostilbene (http://www.pteropure.com/) as a result of its exclusive worldwide patent rights for pterostilbene. For more information, visit http://www.chromadex.com/ or follow ChromaDex on Twitter @ChromaDex.

Investor Inquiries
Liviakis Financial Communications, Inc.
John M. Liviakis, President
415-389-4670
John@Liviakis.com

ChromaDex Contact
Jenny Robles
Administrative Assistant to the CEO
10005 Muirlands Blvd, Suite G, Irvine, CA 92618
949-419-0288
jennyr@chromadex.com

Media Contact
Megan Lavine
Canale Communications
4010 Goldfinch St., San Diego, CA 92103
619-849-5388